Compounds > camptothecin
Page last updated: 2024-08-22

camptothecin and Dihydropyrimidine Dehydrogenase Deficiency

camptothecin has been researched along with Dihydropyrimidine Dehydrogenase Deficiency in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Al-Rajabi, R; Carroll, E; Diab, O; Kasi, A; Melancon, T; Rawlley, B1
Bossi, I; Cheli, S; Clementi, E; de Braud, F; Di Bartolomeo, M; Falvella, FS; Gariboldi, M; Iacovelli, R; Maggi, C; Martinetti, A; Mazzali, C; Mennitto, R; Pierotti, MA; Pietrantonio, F; Sottotetti, E1
Crews, KR1

Other Studies

3 other study(ies) available for camptothecin and Dihydropyrimidine Dehydrogenase Deficiency

ArticleYear
Dual deficiency of DPD and UGT1A1 in a case of colon cancer.
    Pharmacogenomics, 2020, Volume: 21, Issue:18

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; Dihydropyrimidine Dehydrogenase Deficiency; Female; Fluorouracil; Glucuronosyltransferase; Humans; Irinotecan; Leucovorin; Middle Aged; Mutation; Tomography, X-Ray Computed

2020
DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan.
    British journal of clinical pharmacology, 2015, Volume: 80, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Dihydropyrimidine Dehydrogenase Deficiency; Dihydrouracil Dehydrogenase (NADP); Female; Fluorouracil; Glucuronosyltransferase; Heterozygote; Homozygote; Humans; Leucovorin; Male; MicroRNAs; Middle Aged; Organoplatinum Compounds; Polymorphism, Single Nucleotide; Prospective Studies

2015
Individualizing chemotherapeutic treatment of colorectal cancer.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2006, May-01, Volume: 63, Issue:9 Suppl 2

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bilirubin; Biomarkers, Tumor; Camptothecin; Cetuximab; Colorectal Neoplasms; Dihydropyrimidine Dehydrogenase Deficiency; Fluorouracil; Glucuronosyltransferase; Humans; Irinotecan; Pharmacogenetics; United States

2006